BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17617454)

  • 1. Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed.
    Smolej L; Andrys C; Vroblova V
    Leuk Res; 2007 Dec; 31(12):1763-4. PubMed ID: 17617454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
    Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
    Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
    Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
    Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
    Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
    J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
    Letestu R; Rawstron A; Ghia P; Villamor N; Boeckx N; Boettcher S; Buhl AM; Duerig J; Ibbotson R; Kroeber A; Langerak A; Le Garff-Tavernier M; Mockridge I; Morilla A; Padmore R; Rassenti L; Ritgen M; Shehata M; Smolewski P; Staib P; Ticchioni M; Walker C; Ajchenbaum-Cymbalista F
    Cytometry B Clin Cytom; 2006 Jul; 70(4):309-14. PubMed ID: 16906588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome.
    Kay S; Herishanu Y; Pick M; Rogowski O; Baron S; Naparstek E; Polliack A; Deutsch VR
    Cytometry B Clin Cytom; 2006 Jul; 70(4):218-26. PubMed ID: 16456869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ZAP-70 in B-cell chronic lymphocytic leukemia: clinical significance and methods of detection].
    Smolej L; Saudková L; Spacek M; Kozák T
    Vnitr Lek; 2006 Dec; 52(12):1194-9. PubMed ID: 17299914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia.
    Wiestner A
    Cytometry B Clin Cytom; 2006 Jul; 70(4):201-3. PubMed ID: 16906579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of basic fibroblast growth factor and vascular endothelial growth factor and their association with IgVH mutation status in patients with B-cell chronic lymphocytic leukemia.
    Smolej L; Andrys C; Peková S; Schwarz J; Belada D; Zák P
    Haematologica; 2006 Oct; 91(10):1432-3. PubMed ID: 17018398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
    Passam F; Tachynopoulou V; Skoumi D; Tsompanakou A; Stavropoulos-Giokas A; Vadikolia C; Anagnostopoulos A; Paterakis G
    Ann Hematol; 2006 Nov; 85(11):795-805. PubMed ID: 16871389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
    Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
    Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status.
    Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J
    Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.